Active Funding Opportunities and Notices for NICHD

NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.

NOTs and Active NOFOs for NICHD

Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.

Number Exp. Date Sort descending Activity Code(s) Title
PAR-21-115 January 8, 2025 R01 Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)
PA-21-201 January 8, 2025 R01 Research on Autism Spectrum Disorders (R01 Clinical Trial Optional)
PAR-21-357 January 8, 2025 R15 Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)
PAR-22-060 January 8, 2025 R15 Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
NOT-HL-22-025 January 8, 2025 R01 Notice of Special Interest (NOSI): Respiratory Complications of the Muscular Dystrophies (R01)
NOT-HD-22-038 January 8, 2025 R15,R03,R01,R21 Notice of Special Interest (NOSI): Research on the Impact of Policy Changes and Emerging and Evolving Public Health Crises on NICHD Populations of Interest
PAR-21-305 January 10, 2025 R01 Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)
NOT-DK-24-014 January 10, 2025 Notice of Change to Extend Application Due Dates for PAR-21-305 - Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)
PAR-23-114 January 18, 2025 R25 Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25 Clinical Trial Not Allowed)
RFA-MH-25-100 January 18, 2025 U01 BRAIN Initiative: Scaled reagent resources for brain cell type-specific access across vertebrate species (U01 Clinical Trial Not Allowed)
RFA-NS-24-021 February 7, 2025 R01 HEAL Initiative: Understanding Individual Differences in Human Pain Conditions (R01 - Clinical Trial Optional)
RFA-NS-24-014 February 11, 2025 R25 NIH Blueprint and BRAIN Initiative Program for Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (BP BRAIN-ENDURE) (R25 Clinical Trial Not Allowed)
NOT-AI-23-009 February 14, 2025 333 Notice of Special Interest (NOSI): Administrative Supplements to Prepare Data Assets for Infectious and Immune-mediated Diseases for Inclusion into the NIAID Data Ecosystem
NOT-OD-24-044 February 14, 2025 R21 Notice of Special Interest (NOSI): Use of Digital Technology and Mobile Health (mHealth) to Improve Diagnosis, Assessments, Interventions, Management and Outcomes for Individuals with Down Syndrome Across the Lifespan (R21 Clinical Trial Not Allowed)
RFA-NS-22-022 March 12, 2025 K99/R00 HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (K99/R00 Independent Clinical Trial Not Allowed)
RFA-NS-22-023 March 12, 2025 K99/R00 HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (Independent Basic Experimental Studies with Humans Required)
RFA-NS-22-024 March 12, 2025 K99/R00 HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Basic Experimental Studies with Humans Required)
RFA-NS-22-025 March 12, 2025 K99/R00 HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
NOT-HD-22-049 March 16, 2025 R01,R03,R21 "Notice of Special Interest (NOSI): High Priority Areas in Placental Research for Healthy Pregnancies" (Reissue)
NOT-OD-22-142 March 17, 2025 R21 Notice of Special Interest (NOSI): Community-Based Participatory Research (CBPR) Initiative in Reducing and Eliminating Health Disparities with a focus on addressing diverse representation in research on Down syndrome (R21 Clinical Trial Optional)
top of pageBACK TO TOP